The Technical Analyst
Select Language :

MyMD Pharmaceuticals, [MYMD]

Exchange: Sector: Healthcare Industry: Biotechnology

Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

MyMD Pharmaceuticals, is listed at the NASDAQ Exchange

7.61% $7.64

Last updated: 28 Nov 2021 @ 16:55 pm


FUNDAMENTALS
MarketCap: 287.57 mill
EPS: -0.812
P/E: 0.000
Earnings Date: Nov 12, 2021
SharesOutstanding: 37.64 mill
Avg Daily Volume: 0.215 mill
RATING 2021-11-26
B
Neutral
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/203/204/201/212/213/21
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debtn/an/a
PE RATIO: COMPANY / SECTOR
nanx
Company: PE 0.000 | sector: PE nan
PE RATIO: COMPANY / INDUSTRY
nanx
Company: PE 0.000 | industry: PE nan
DISCOUNTED CASH FLOW VALUE
$10.28
(34.55%) $2.64
Date: 2021-11-28

Insider Trading

Date Person Action Amount type
2021-11-23 Rivard Paul Buy 15 000 Common stock
2021-10-14 Kaplin Adam Buy 600 000 Restricted Stock Units
2021-10-14 Rivard Paul Buy 200 000 Restricted Stock Units
2021-10-14 Chapman Christopher C Jr Buy 600 000 Restricted Stock Units
2021-10-14 Silverman Joshua Buy 600 000 Restricted Stock Units
INSIDER POWER
80.40
Last 89 transactions
Buy: 6 439 795 | Sell: 684 825

Forecast: 14:40 - $7.66

Live Trading Signals (every 1 min)

Forecast 1: 13:10 - $7.66
Forecast 2: 14:00 - $7.67
Forecast 3: 14:40 - $7.66
SCORE
-1.13
Sell
Score Algorithm Version: 0.9M
Last version updated: Thurs 28th Oct 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $7.64 (7.61% )
Volume 0.194 mill
Avg. Vol. 0.215 mill
% of Avg. Vol 90.24 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for MyMD Pharmaceuticals, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for MyMD Pharmaceuticals, Inc.

RSI

Intraday RSI14 chart for MyMD Pharmaceuticals, Inc.
The Live Chart for MyMD Pharmaceuticals, Inc.
Profile picture for
            MyMD Pharmaceuticals, Inc.

MYMD

Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. The company is headquartered in West Deptford, New Jersey and currently employs 28 full-time employees. The firm's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The firm's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The firm's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Last 10 Buy Signals
Date Signal @
XRPUSDNov 28 - 11:510.918
XRPUSDNov 28 - 11:440.914
BTCUSDNov 28 - 11:2954 102
DOGEUSDNov 28 - 11:29$0.198
XRPUSDNov 28 - 11:230.920
XRPUSDNov 28 - 11:100.924
XRPUSDNov 28 - 10:590.926
XRPUSDNov 28 - 10:550.928
BTCUSDNov 28 - 10:5354 420
DOGEUSDNov 28 - 10:46$0.201

Stock Peers

Company Price Change
MYMD7.647.61%
ABEO0.730-3.57%
AIH3.31-4.34%
CALA0.9011.46%
CFMS0.930-4.81%
CFRX3.523.23%
CMPI3.58-4.28%
EVGN2.030.50%
EYES2.09-1.42%
GRTX1.470-2.00%
ONCY1.810-3.72%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.